Cancer Fund
VC Fund
Phoenix, United States
Cancer Fund is a VC fund in Phoenix focused on Health Care and Medical. Cancer Fund aims to generate impact and returns by advancing cancer innovations beyond research toward, or through, regulatory approvals, technical validation, or earliest market adoption. FUND I is designed to make up to $30M in pre-seed through Series D investors in therapies & management, diagnostic & monitoring, and prevention &enabling technology solutions with the potential to improve patient outcomes, increase access to care, or reduce cost of care.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Cancer Fund invests in
Stages Cancer Fund invests in
Countries Cancer Fund invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Ajay Bhatnagar
|
|||
Anita Gupta
|
|||
Ann Low
|
|||
Edward Cho
|
|||
Jeff Rea
|
|||
| See all 8 contacts → | |||
Investment Focus
Industry
- Health Care 2 (67%)
- Medical 1 (33%)
- Biotechnology 1 (33%)
- Medical Device 1 (33%)
- Health Diagnostics 1 (33%)
Stage
- Seed 1 (33%)
- Series A 1 (33%)
- Funding Round 1 (33%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Ajay Bhatnagar
Chief Medical Officer
|
Chief Medical Officer | Total investments: 0 | Find email | |
|
Anita Gupta
Venture Partner
|
Venture Partner | Total investments: 0 | Find email | |
|
Ann Low
Co-Founder
|
Co-Founder | Total investments: 0 | Find email | |
|
Edward Cho
Venture Partner
|
Venture Partner | Total investments: 0 | Find email | |
|
Jeff Rea
Co-Founder
|
Co-Founder | Total investments: 0 | Find email | |
| See all 8 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Cellens
|
Cellens is a medical device company that provides clarity and focus on cancer detection. Cellens is a Tufts University spinoff company dedicated to providing patients and doctors with clarity and confidence through noninvasive cancer screening. It was founded in 2019 and is based in Medford, Massachusetts. | $6.5M / Seed / Dec 23, 2025 | |
AOA
|
AOA Dx is a biotechnology company with a team of entrepreneurs that brings innovative, impactful, and cost-effective medical technologies from research and development into the hands of providers and patients. The company is driven by a mission to bring to market the first accurate early-stage non-invasive ovarian cancer diagnostic test that willimprove clinical practice and help reduce patient mortality. | $17M / Oct 11, 2023 | |
|
AOA
|
AOA Dx is a biotechnology company with a team of entrepreneurs that brings innovative, impactful, and cost-effective medical technologies from research and development into the hands of providers and patients. The company is driven by a mission to bring to market the first accurate early-stage non-invasive ovarian cancer diagnostic test that willimprove clinical practice and help reduce patient mortality. | $17M / Series A / Oct 11, 2023 |
Co-Investors
LabCorp Venture Fund
3 deals together
Adaptive Capital Partners
2 deals together
FemHealth Ventures
2 deals together
Good Growth Capital
2 deals together
Gore Range Capital
2 deals together
LongeVC
2 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Cancer Fund invest in?
Cancer Fund invests primarily in Health Care, Medical and Biotechnology startups, most often at Seed and Series A stage. Most of the 3 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Cancer Fund?
Public channels for Cancer Fund include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Cancer Fund?
The team at Cancer Fund includes Ajay Bhatnagar (Chief Medical Officer), Anita Gupta (Venture Partner) and Ann Low (Co-Founder), among 8 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
